All research
Human early-phase trial / 2006
Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295 in healthy adults
Teichman SL, Neale A, Lawrence B, et al.
Study overview
Early randomized studies in healthy adults measured changes in circulating growth hormone and IGF-I after the long-acting GHRH analogue CJC-1295.
Results are specific to the study. This is an editorial summary, not personal treatment advice.
Study limitations
Hormone concentrations are surrogate endpoints. These short studies do not establish benefits for recovery, body composition, or long-term safety. Long-acting CJC-1295 must not be conflated with other products sold under similar names.
About this summary
This summary uses the cited abstract and bibliographic record. Read the original methods and results for the full context.